UBS Group AG - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 45 filers reported holding OBALON THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$2,000
-50.0%
3,031
+21.2%
0.00%
Q1 2019$4,000
-75.0%
2,500
-68.8%
0.00%
Q4 2018$16,000
-88.7%
8,015
-84.7%
0.00%
Q3 2018$142,000
+140.7%
52,325
+88.6%
0.00%
Q2 2018$59,000
-53.2%
27,751
-24.2%
0.00%
Q1 2018$126,000
-39.4%
36,594
+16.4%
0.00%
Q4 2017$208,000
+27.6%
31,442
+84.6%
0.00%
Q3 2017$163,000
-2.4%
17,036
+1.0%
0.00%
Q2 2017$167,000
+31.5%
16,859
+42.2%
0.00%
Q1 2017$127,000
+130.9%
11,856
+90.8%
0.00%
Q4 2016$55,0006,2150.00%
Other shareholders

There were no reported owners of OBALON THERAPEUTICS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of OBALON THERAPEUTICS INC shareholders